Company Data
Outlook Therapeutics Inc.
Ticker
OTLK
Current Price
$8.22 0.24%
Market Cap
$107.0M
Price Target
Refer to Report
Volume
105.0K
52wk Range
$4.004 - $40.6
Overview
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.